Key result
Pegylated interferon alpha plus ribavirin for chronic hepatitis C may induce thyrotoxic periodic paralysis.
Pegylated interferon alpha plus ribavirin for chronic hepatitis C may induce thyrotoxic periodic paralysis.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to rare paralysis risk during interferon therapy; case evidence leaves causality and incidence open for study.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2008) studied this question. Pegylated interferon alpha plus ribavirin therapy for chronic hepatitis C can induce thyrotoxic periodic paralysis.
Synapse has enriched 10 related papers. Consider them for comparative context: